FDA Inspection 1193412 - Nephron Pharmaceuticals - December 02, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Nephron Pharmaceuticals, with an inspection on December 2, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Nephron Pharmaceuticals
Inspection Date: December 2, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 8588565d-d892-4b72-b6c2-bd1fbf800234